Discover

AVTE
Aerovate Therapeutics, Inc.
9.80
undefined x undefined
undefined x undefined
bid
ask
+
0.00
0.00%
04:00 PM
timesize
Ytd
1y
92.04
day range
96.95
2.63
52 week range
884.98
Open93.10Prev Close9.80Low92.04High96.95Mkt Cap77.68M
Vol0.00Avg Vol7.99KEPS-59.50P/E-0.05Forward P/E-2.60
Beta0.95Short Ratio0.98Inst. Own102.17%DividendN/ADiv YieldN/A
Ex Div DateN/AEarningN/A50-d Avg88.74200-d Avg82.181yr Est2.33

AVTE News

Aerovate Therapeutics (NASDAQ:AVTE) & AEON Biopharma (NASDAQ:AEON) Head to Head Survey
defenseworld.net
Aerovate Therapeutics (NASDAQ:AVTE) & AEON Biopharma (NASDAQ:AEON) Head to Head Survey

Aerovate Therapeutics (NASDAQ: AVTE - Get Free Report) and AEON Biopharma (NASDAQ: AEON - Get Free R

Aerovate Therapeutics (NASDAQ:AVTE) Trading Down 0.5%  – Here’s Why
defenseworld.net
Aerovate Therapeutics (NASDAQ:AVTE) Trading Down 0.5% – Here’s Why

Aerovate Therapeutics, Inc. (NASDAQ: AVTE - Get Free Report) dropped 0.5% during mid-day trading on

Reviewing Aerovate Therapeutics (NASDAQ:AVTE) & Graybug Vision (NASDAQ:GRAY)
defenseworld.net
Reviewing Aerovate Therapeutics (NASDAQ:AVTE) & Graybug Vision (NASDAQ:GRAY)

Volatility and Risk Aerovate Therapeutics has a beta of 0.95, suggesting that its stock price is 5%

19,564 Shares in Aerovate Therapeutics, Inc. (NASDAQ:AVTE) Purchased by Squarepoint Ops LLC
https://www.defenseworld.net
19,564 Shares in Aerovate Therapeutics, Inc. (NASDAQ:AVTE) Purchased by Squarepoint Ops LLC

Squarepoint Ops LLC bought a new stake in shares of Aerovate Therapeutics, Inc. (NASDAQ:AVTE –

Jade Biosciences Completes Closing of Merger with Aerovate Therapeutics and Previously Announced Private Placement of Approximately $300 Million
globenewswire.com
Jade Biosciences Completes Closing of Merger with Aerovate Therapeutics and Previously Announced Pri

Company is advancing portfolio of novel therapies that aim to redefine the standard of care for pati

Aerovate Therapeutics Stockholders Approve Proposed Merger with Jade Biosciences and All Related Proposals
prnewswire.com
Aerovate Therapeutics Stockholders Approve Proposed Merger with Jade Biosciences and All Related Pro

—Aerovate Board of Directors approves 1-for-35 reverse stock split— WALTHAM, Mass. , April 21, 2025

Aerovate Therapeutics Declares Special Cash Dividend in Connection with the Proposed Merger with Jade Biosciences
prnewswire.com
Aerovate Therapeutics Declares Special Cash Dividend in Connection with the Proposed Merger with Jad

Aggregate cash dividend of $69.6 million, or an estimated $2.40 per share WALTHAM, Mass. , April 9,

Aerovate Therapeutics Announces Range of Expected Cash Dividend in Connection with the Proposed Merger with Jade Biosciences
prnewswire.com
Aerovate Therapeutics Announces Range of Expected Cash Dividend in Connection with the Proposed Merg

Cash dividend expected to be in the range of $67.6 – 69.6 million WALTHAM, Mass. , April 7, 2025 /PR

AEROVATE THERAPEUTICS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Merger of Aerovate Therapeutics, Inc. - AVTE
businesswire.com
AEROVATE THERAPEUTICS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti,

NEW YORK CITY & NEW ORLEANS--(BUSINESS WIRE)--Former Attorney General of Louisiana Charles C. Foti,

AVTE Stock Alert: Halper Sadeh LLC Is Investigating Whether the Merger of Aerovate Therapeutics, Inc. Is Fair to Shareholders
businesswire.com
AVTE Stock Alert: Halper Sadeh LLC Is Investigating Whether the Merger of Aerovate Therapeutics, Inc

NEW YORK--(BUSINESS WIRE)--Halper Sadeh LLC, an investor rights law firm, is investigating whether t

INVESTOR ALERT: The M&A Class Action Firm Investigates the Merger of Aerovate Therapeutics, Inc. – AVTE
globenewswire.com
INVESTOR ALERT: The M&A Class Action Firm Investigates the Merger of Aerovate Therapeutics, Inc. – A

NEW YORK, Nov. 05, 2024 (GLOBE NEWSWIRE) -- Monteverde & Associates PC (the “M&A Class Action Firm”)

INVESTOR ALERT: The M&A Class Action Firm Investigates the Merger of Aerovate Therapeutics, Inc. - AVTE
prnewswire.com
INVESTOR ALERT: The M&A Class Action Firm Investigates the Merger of Aerovate Therapeutics, Inc. - A

NEW YORK , Nov. 3, 2024 /PRNewswire/ --  Monteverde & Associates PC (the "M&A Class Action Firm"), h

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates AVTE and PFIE on Behalf of Shareholders
prnewswire.com
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates AVTE and PFIE on Behalf of Shareholders

NEW YORK , Nov. 1, 2024 /PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigat

AVTE Stock Alert: Halper Sadeh LLC Is Investigating Whether the Merger of Aerovate Therapeutics, Inc. Is Fair to Shareholders
businesswire.com
AVTE Stock Alert: Halper Sadeh LLC Is Investigating Whether the Merger of Aerovate Therapeutics, Inc

NEW YORK--(BUSINESS WIRE)--Halper Sadeh LLC, an investor rights law firm, is investigating whether t

Shareholder Alert: Ademi LLP Investigates Whether Aerovate Therapeutics, Inc. Is Obtaining a Fair Price for Its Public Shareholders
businesswire.com
Shareholder Alert: Ademi LLP Investigates Whether Aerovate Therapeutics, Inc. Is Obtaining a Fair Pr

MILWAUKEE--(BUSINESS WIRE)--Ademi LLP is investigating Aerovate (Nasdaq: AVTE) for possible breaches

Aerovate Therapeutics to Explore Strategic Alternatives
globenewswire.com
Aerovate Therapeutics to Explore Strategic Alternatives

WALTHAM, Mass., July 08, 2024 (GLOBE NEWSWIRE) -- Aerovate Therapeutics, Inc. (Nasdaq: AVTE), which

The 3 Hottest Stock Downgrades From Last Week
investorplace.com
The 3 Hottest Stock Downgrades From Last Week

Wall Street's leading analysts have been adjusting their S&P 500 forecasts in recent days. Driven by

Investigation Into Aerovate Therapeutics, Inc. (AVTE) Announced byHolzer & Holzer, LLC
globenewswire.com
Investigation Into Aerovate Therapeutics, Inc. (AVTE) Announced byHolzer & Holzer, LLC

ATLANTA, June 21, 2024 (GLOBE NEWSWIRE) -- Holzer & Holzer, LLC is investigating whether Aerovate Th

Aerovate Therapeutics Investors: Investigation on behalf of investors; the Portnoy Law Firm
globenewswire.com
Aerovate Therapeutics Investors: Investigation on behalf of investors; the Portnoy Law Firm

Investors can contact the law firm at no cost to learn more about recovering their losses

Aerovate (AVTE) Down as Lead Drug Fails to Meet PAH Study Goals
zacks.com
Aerovate (AVTE) Down as Lead Drug Fails to Meet PAH Study Goals

Aerovate's (AVTE) shares plunge 93% as its lead candidate, AV-101, fails to meet the primary and sec

benzinga.com
Stocks That Hit 52-Week Lows On Thursday

  During the session on Thursday, 461 stocks hit new 52-week lows.